Trusted Resource for Clinical Trials, Protocols & Progress
The purpose of this SOP is to define the process for preparing the Final Clinical Study Report (CSR) according to ICH E3 guidelines and applicable regulatory requirements (FDA, EMA, CDSCO, WHO). The CSR provides a comprehensive, accurate, and transparent account of study objectives, methodology, conduct, results, and conclusions for regulatory and scientific audiences.
Click to read the full article.
The purpose of this SOP is to outline procedures for registering clinical trials and posting results in publicly accessible registries such as ClinicalTrials.gov, EU CTR/CTIS, and WHO ICTRP. This ensures regulatory compliance, promotes transparency, and supports global commitments to public disclosure of trial information.
Click to read the full article.
The purpose of this SOP is to outline the publication policy and disclosure/transparency practices for clinical trials. It ensures accurate, timely, and unbiased dissemination of trial results to regulatory agencies, investigators, participants, and the public while meeting global regulatory and ethical requirements.
Click to read the full article.
The purpose of this SOP is to define procedures for the secure and compliant sharing of clinical trial data with regulators and public repositories. Data sharing enhances transparency, facilitates regulatory review, and supports global scientific collaboration while protecting subject confidentiality.
Click to read the full article.
